Follitropin alfa biosimilar (Qilu Pharmaceutical)

促卵泡激素α生物类似药 (齐鲁制药)

Report date: 2026/04/21 20:00:18

Base Information

Drug NameFollitropin alfa biosimilar (Qilu Pharmaceutical)
Drug Alias NameQL-1012QL1012D
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, FemaleAnovulationInfertility
Global Approved IndicationsInfertility, Female
Approved Indications in ChinaInfertility, Female
Original Approved Country/TerritoryMainland China
Original Approved Date2021/12/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInfertility, Female
Inactive IndicationsAnovulationInfertility

Other Information

ATC CodeG03GA05
Related LinksN/A